FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085070912> ?p ?o ?g. }

• W2085070912 endingPage "1622" @default.
• W2085070912 startingPage "1613" @default.
• W2085070912 abstract "ObjectiveTo develop an immunomagnetic cell separation system for allogeneic hematopoietic stem cell (HSC) transplantations, which can achieve a high level of T-cell depletion (at least 4.0 log10), high level of recovery of hematopoietic stem cells (>90%), with a high throughput (>106 cells/second).MethodsPeripheral blood leukocytes (PBLs) from buffy coats were spiked with CD34-expressing cells (KG1a) to mimic a leukaphoresis product containing stimulated HSCs. T cells were labeled with anti-CD3+ Dynabeads and separated in a quadrupole magnetic cell sorter (QMS). The performance of the system with respect to T-cell depletion and recovery of non–T cells and spiked KG1a was determined using four-color, flow cytometry analysis, with the aid of Trucount cell-concentration calibration beads. Limiting dilution assays were also performed to quantify the log10 depletion of clonable T cells.ResultsWhile the general performance of the QMS system is governed by proven theoretical principles, significant system variability exist, not all of which can be explained by our current understanding. Consequently, a factorial design was employed, guided by JMP software, to optimize the labeling conditions and operation of the QMS focused on maximizing the depletion of T cell, and recovery of unlabeled cells including KG1a cells. From these studies, an optimized, no wash, immunomagnetic labeling protocol and optimized QMS operating conditions were developed. For an average initial cell concentration of 1.7 × 108 total cells, an average 3.96 ± 0.33 log10 depletion (range, 3.53–4.34) of CD3+CD45+ cells with a mean 99.43% ± 4.23% recovery of CD34+CD45+ cells (range, 94.38–104.90%) was achieved at a sorting speed of 106 cells/s (n = 6). Limiting dilution assays on the T-cell depleted fractions, which gave a log10 depletion of 3.51 for the clonable T cells.ConclusionWe suggest that this system will provide superior performance with respect to T-cell depletion and CD34+ recovery for clinical allogeneic bone marrow transplants. Ongoing studies, on a clinical scale, are being conducted to demonstrate this claim. To develop an immunomagnetic cell separation system for allogeneic hematopoietic stem cell (HSC) transplantations, which can achieve a high level of T-cell depletion (at least 4.0 log10), high level of recovery of hematopoietic stem cells (>90%), with a high throughput (>106 cells/second). Peripheral blood leukocytes (PBLs) from buffy coats were spiked with CD34-expressing cells (KG1a) to mimic a leukaphoresis product containing stimulated HSCs. T cells were labeled with anti-CD3+ Dynabeads and separated in a quadrupole magnetic cell sorter (QMS). The performance of the system with respect to T-cell depletion and recovery of non–T cells and spiked KG1a was determined using four-color, flow cytometry analysis, with the aid of Trucount cell-concentration calibration beads. Limiting dilution assays were also performed to quantify the log10 depletion of clonable T cells. While the general performance of the QMS system is governed by proven theoretical principles, significant system variability exist, not all of which can be explained by our current understanding. Consequently, a factorial design was employed, guided by JMP software, to optimize the labeling conditions and operation of the QMS focused on maximizing the depletion of T cell, and recovery of unlabeled cells including KG1a cells. From these studies, an optimized, no wash, immunomagnetic labeling protocol and optimized QMS operating conditions were developed. For an average initial cell concentration of 1.7 × 108 total cells, an average 3.96 ± 0.33 log10 depletion (range, 3.53–4.34) of CD3+CD45+ cells with a mean 99.43% ± 4.23% recovery of CD34+CD45+ cells (range, 94.38–104.90%) was achieved at a sorting speed of 106 cells/s (n = 6). Limiting dilution assays on the T-cell depleted fractions, which gave a log10 depletion of 3.51 for the clonable T cells. We suggest that this system will provide superior performance with respect to T-cell depletion and CD34+ recovery for clinical allogeneic bone marrow transplants. Ongoing studies, on a clinical scale, are being conducted to demonstrate this claim." @default.
• W2085070912 created "2016-06-24" @default.
• W2085070912 creator A5026930111 @default.
• W2085070912 creator A5035471908 @default.
• W2085070912 creator A5049828491 @default.
• W2085070912 creator A5056697792 @default.
• W2085070912 creator A5077991708 @default.
• W2085070912 date "2007-10-01" @default.
• W2085070912 modified "2023-10-10" @default.
• W2085070912 title "A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation" @default.
• W2085070912 cites W1962521045 @default.
• W2085070912 cites W1963920939 @default.
• W2085070912 cites W2003050944 @default.
• W2085070912 cites W2010071686 @default.
• W2085070912 cites W2010964177 @default.
• W2085070912 cites W2015702737 @default.
• W2085070912 cites W2041071832 @default.
• W2085070912 cites W2043394674 @default.
• W2085070912 cites W2050337764 @default.
• W2085070912 cites W2050921203 @default.
• W2085070912 cites W2054528330 @default.
• W2085070912 cites W2058506291 @default.
• W2085070912 cites W2061411387 @default.
• W2085070912 cites W2063939693 @default.
• W2085070912 cites W2080419855 @default.
• W2085070912 cites W2087188884 @default.
• W2085070912 cites W2101702420 @default.
• W2085070912 cites W2106617966 @default.
• W2085070912 cites W2117743050 @default.
• W2085070912 cites W2161514484 @default.
• W2085070912 cites W2169663475 @default.
• W2085070912 cites W2206561315 @default.
• W2085070912 cites W2302206374 @default.
• W2085070912 cites W231256306 @default.
• W2085070912 cites W2317548431 @default.
• W2085070912 cites W2318697095 @default.
• W2085070912 cites W2325823885 @default.
• W2085070912 cites W2335614859 @default.
• W2085070912 cites W4253353540 @default.
• W2085070912 doi "https://doi.org/10.1016/j.exphem.2007.06.015" @default.
• W2085070912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2094009" @default.
• W2085070912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17697744" @default.
• W2085070912 hasPublicationYear "2007" @default.
• W2085070912 type Work @default.
• W2085070912 sameAs 2085070912 @default.
• W2085070912 citedByCount "21" @default.
• W2085070912 countsByYear W20850709122012 @default.
• W2085070912 countsByYear W20850709122013 @default.
• W2085070912 countsByYear W20850709122014 @default.
• W2085070912 countsByYear W20850709122016 @default.
• W2085070912 countsByYear W20850709122017 @default.
• W2085070912 countsByYear W20850709122020 @default.
• W2085070912 countsByYear W20850709122021 @default.
• W2085070912 crossrefType "journal-article" @default.
• W2085070912 hasAuthorship W2085070912A5026930111 @default.
• W2085070912 hasAuthorship W2085070912A5035471908 @default.
• W2085070912 hasAuthorship W2085070912A5049828491 @default.
• W2085070912 hasAuthorship W2085070912A5056697792 @default.
• W2085070912 hasAuthorship W2085070912A5077991708 @default.
• W2085070912 hasBestOaLocation W20850709121 @default.
• W2085070912 hasConcept C109159458 @default.
• W2085070912 hasConcept C126322002 @default.
• W2085070912 hasConcept C1491633281 @default.
• W2085070912 hasConcept C153911025 @default.
• W2085070912 hasConcept C185592680 @default.
• W2085070912 hasConcept C2778903051 @default.
• W2085070912 hasConcept C2781053203 @default.
• W2085070912 hasConcept C28328180 @default.
• W2085070912 hasConcept C2911091166 @default.
• W2085070912 hasConcept C553184892 @default.
• W2085070912 hasConcept C55493867 @default.
• W2085070912 hasConcept C71924100 @default.
• W2085070912 hasConcept C86803240 @default.
• W2085070912 hasConcept C95444343 @default.
• W2085070912 hasConceptScore W2085070912C109159458 @default.
• W2085070912 hasConceptScore W2085070912C126322002 @default.
• W2085070912 hasConceptScore W2085070912C1491633281 @default.
• W2085070912 hasConceptScore W2085070912C153911025 @default.
• W2085070912 hasConceptScore W2085070912C185592680 @default.
• W2085070912 hasConceptScore W2085070912C2778903051 @default.
• W2085070912 hasConceptScore W2085070912C2781053203 @default.
• W2085070912 hasConceptScore W2085070912C28328180 @default.
• W2085070912 hasConceptScore W2085070912C2911091166 @default.
• W2085070912 hasConceptScore W2085070912C553184892 @default.
• W2085070912 hasConceptScore W2085070912C55493867 @default.
• W2085070912 hasConceptScore W2085070912C71924100 @default.
• W2085070912 hasConceptScore W2085070912C86803240 @default.
• W2085070912 hasConceptScore W2085070912C95444343 @default.
• W2085070912 hasIssue "10" @default.
• W2085070912 hasLocation W20850709121 @default.
• W2085070912 hasLocation W20850709122 @default.
• W2085070912 hasLocation W20850709123 @default.
• W2085070912 hasLocation W20850709124 @default.
• W2085070912 hasOpenAccess W2085070912 @default.
• W2085070912 hasPrimaryLocation W20850709121 @default.
• W2085070912 hasRelatedWork W152891755 @default.
• W2085070912 hasRelatedWork W1990277020 @default.
• W2085070912 hasRelatedWork W1991432514 @default.

• next